FDA warns against co-administration of remdesivir with CQ or HCQ for COVID-19 patients

Hyderabad, June 16 () The US Food and Drug Administration (USFDA) warned healthcare providers against co-administration of Gilead Sciences remdesivir, which received emergency use authorization for COVID-19 patients,...